Amgen(AMGN) - 2024 Q1 - Earnings Call Transcript

Amgen, Inc. (NASDAQ:AMGN) Q1 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Justin Claeys - VP, IR Robert Bradway - Chairman, CEO & President James Bradner - EVP, Research and Development & Chief Scientific Officer Vikram Karnani - EVP & President, Global Commercial Operations & Medical Affairs (Rare Disease) Murdo Gordon - EVP, Global Commercial Operations Peter Griffith - EVP & CFO Conference Call Participants Salveen Richter - Goldman Sachs Group Michael Yee - Jefferies Terence ...